| First Author | Gills JJ | Year | 2006 |
| Journal | Cancer Lett | Volume | 236 |
| Issue | 1 | Pages | 72-9 |
| PubMed ID | 15993536 | Mgi Jnum | J:108563 |
| Mgi Id | MGI:3624241 | Doi | 10.1016/j.canlet.2005.05.007 |
| Citation | Gills JJ, et al. (2006) Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett 236(1):72-9 |
| abstractText | Sulforaphane (SF), a natural product from broccoli, is known to enhance detoxification of carcinogens and block initiation of chemically-induced carcinogenesis in animal models. Cell culture and xenograft studies suggest additional roles for SF, inhibiting growth of tumors, arresting the cell cycle and enhancing apoptosis. As currently reported, topical SF (1, 5 or 10mumol/mouse) significantly inhibited 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol 13-acetate (TPA)-induced mouse skin tumorigenesis, using either an anti-promotion protocol (SF from 1 week after carcinogen until the end of the study) or a combined anti-initiation, anti-promotion protocol (SF 7 days prior to carcinogen until the end of the study). Surprisingly, no significant effect was observed in an anti-initiation protocol (SF from 7 days prior to 7 days after carcinogen). Separately, SF inhibited TPA-induced ornithine decarboxylase activity in mouse skin, an obligate step in TPA-induced promotion of carcinogenesis. These data link this molecular mechanism to SF-dependent inhibition of the promotion of tumorigenesis. |
